PortfoliosLab logoPortfoliosLab logo
SOC vs. CCCC
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SOC vs. CCCC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sable Offshore Corp (SOC) and C4 Therapeutics, Inc. (CCCC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SOC achieves a 45.45% return, which is significantly lower than CCCC's 87.96% return.


SOC

1D
7.10%
1M
2.10%
YTD
45.45%
6M
133.87%
1Y
-46.45%
3Y*
5Y*
10Y*

CCCC

1D
-6.75%
1M
21.69%
YTD
87.96%
6M
41.34%
1Y
107.51%
3Y*
1.04%
5Y*
-38.85%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

SOC vs. CCCC - Yearly Performance Comparison


2026 (YTD)20252024
SOC
Sable Offshore Corp
45.45%-60.61%84.53%
CCCC
C4 Therapeutics, Inc.
87.96%-46.94%-54.43%

Correlation

The correlation between SOC and CCCC is -0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.02

Correlation (All Time)
Calculated using the full available price history since Feb 16, 2024

0.07

Fundamentals

Market Cap

SOC:

$1.88T

CCCC:

$452.61M

EPS

SOC:

-$0.01

CCCC:

-$1.18

PS Ratio

SOC:

371.49K

CCCC:

11.02

PB Ratio

SOC:

4.47K

CCCC:

1.93

Total Revenue (TTM)

SOC:

$1.27M

CCCC:

$28.71M

Gross Profit (TTM)

SOC:

-$11.08M

CCCC:

$26.90M

EBITDA (TTM)

SOC:

-$337.95M

CCCC:

-$107.31M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SOC vs. CCCC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SOC
SOC Risk / Return Rank: 3131
Overall Rank
SOC Sharpe Ratio Rank: 2828
Sharpe Ratio Rank
SOC Sortino Ratio Rank: 4040
Sortino Ratio Rank
SOC Omega Ratio Rank: 3939
Omega Ratio Rank
SOC Calmar Ratio Rank: 2323
Calmar Ratio Rank
SOC Martin Ratio Rank: 2626
Martin Ratio Rank

CCCC
CCCC Risk / Return Rank: 7575
Overall Rank
CCCC Sharpe Ratio Rank: 7474
Sharpe Ratio Rank
CCCC Sortino Ratio Rank: 8080
Sortino Ratio Rank
CCCC Omega Ratio Rank: 7474
Omega Ratio Rank
CCCC Calmar Ratio Rank: 7676
Calmar Ratio Rank
CCCC Martin Ratio Rank: 7373
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SOC vs. CCCC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sable Offshore Corp (SOC) and C4 Therapeutics, Inc. (CCCC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SOCCCCCDifference
Sharpe ratioReturn per unit of total volatility

-1.40

Sortino ratioReturn per unit of downside risk

-1.85

Omega ratioGain probability vs. loss probability

1.04

1.24

-0.20

Calmar ratioReturn relative to maximum drawdown

-0.54

2.08

-2.61

Martin ratioReturn relative to average drawdown

-0.85

4.02

-4.87

SOC vs. CCCC - Sharpe Ratio Comparison

The current SOC Sharpe Ratio is -0.33, which is lower than the CCCC Sharpe Ratio of 1.07. The chart below compares the historical Sharpe Ratios of SOC and CCCC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


SOCCCCCDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.33

1.07

-1.40

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.33

Sharpe Ratio (All Time)

Calculated using the full available price history

0.02

-0.26

+0.28

Drawdowns

SOC vs. CCCC - Drawdown Comparison

The maximum SOC drawdown since its inception was -87.52%, smaller than the maximum CCCC drawdown of -97.82%. Use the drawdown chart below to compare losses from any high point for SOC and CCCC.


Loading charts...

Drawdown Indicators


SOCCCCCDifference

Max Drawdown

Largest peak-to-trough decline

-87.52%

-97.82%

+10.30%

Max Drawdown (1Y)

Largest decline over 1 year

-87.00%

-52.10%

-34.90%

Max Drawdown (3Y)

Largest decline over 3 years

-90.00%

Max Drawdown (5Y)

Largest decline over 5 years

-97.82%

Current Drawdown

Current decline from peak

-60.27%

-92.89%

+32.62%

Average Drawdown

Average peak-to-trough decline

-30.80%

-71.93%

+41.13%

Ulcer Index

Depth and duration of drawdowns from previous peaks

54.76%

26.91%

+27.85%

Volatility

SOC vs. CCCC - Volatility Comparison

The current volatility for Sable Offshore Corp (SOC) is 27.48%, while C4 Therapeutics, Inc. (CCCC) has a volatility of 33.23%. This indicates that SOC experiences smaller price fluctuations and is considered to be less risky than CCCC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SOCCCCCDifference

Volatility (1M)

Calculated over the trailing 1-month period

27.48%

33.23%

-5.75%

Volatility (6M)

Calculated over the trailing 6-month period

96.35%

64.03%

+32.32%

Volatility (1Y)

Calculated over the trailing 1-year period

140.85%

101.70%

+39.15%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

111.43%

117.54%

-6.11%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

111.43%

113.15%

-1.72%

Dividends

SOC vs. CCCC - Dividend Comparison

Neither SOC nor CCCC has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

SOC vs. CCCC - Financials Comparison

This section allows you to compare key financial metrics between Sable Offshore Corp and C4 Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M20.00M20222023202420252026
1.27M
0
(SOC) Total Revenue
(CCCC) Total Revenue
Values in USD except per share items

Frequently Asked Questions


SOC and CCCC have a correlation of -0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CCCC has higher volatility (33.23%) compared to SOC (27.48%). In terms of maximum drawdown, SOC dropped -87.52% vs CCCC's -97.82%.

CCCC currently has the higher Sharpe Ratio (1.07 vs -0.33), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SOC and CCCC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer